- Home
- IDYA vs BCAT Comparison
IDYA vs BCAT Comparison
Compare IDYA & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- BCAT
- Stock Information
- Founded
- IDYA 2015
- BCAT 2020
- Country
- IDYA United States
- BCAT United States
- Employees
- IDYA N/A
- BCAT N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- BCAT Finance/Investors Services
- Sector
- IDYA Health Care
- BCAT Finance
- Exchange
- IDYA Nasdaq
- BCAT Nasdaq
- Market Cap
- IDYA 2.2B
- BCAT 1.8B
- IPO Year
- IDYA 2019
- BCAT N/A
- Fundamental
- Price
- IDYA $22.18
- BCAT $15.67
- Analyst Decision
- IDYA Strong Buy
- BCAT
- Analyst Count
- IDYA 13
- BCAT 0
- Target Price
- IDYA $53.67
- BCAT N/A
- AVG Volume (30 Days)
- IDYA 890.0K
- BCAT 308.8K
- Earning Date
- IDYA 02-18-2025
- BCAT 01-01-0001
- Dividend Yield
- IDYA N/A
- BCAT 9.38%
- EPS Growth
- IDYA N/A
- BCAT N/A
- EPS
- IDYA N/A
- BCAT 1.43
- Revenue
- IDYA $3,922,000.00
- BCAT N/A
- Revenue This Year
- IDYA N/A
- BCAT N/A
- Revenue Next Year
- IDYA $251.89
- BCAT N/A
- P/E Ratio
- IDYA N/A
- BCAT $11.41
- Revenue Growth
- IDYA N/A
- BCAT N/A
- 52 Week Low
- IDYA $22.10
- BCAT $13.67
- 52 Week High
- IDYA $47.74
- BCAT $16.38
- Technical
- Relative Strength Index (RSI)
- IDYA 31.90
- BCAT 51.73
- Support Level
- IDYA $22.17
- BCAT $15.40
- Resistance Level
- IDYA $24.06
- BCAT $15.76
- Average True Range (ATR)
- IDYA 1.06
- BCAT 0.22
- MACD
- IDYA -0.22
- BCAT 0.06
- Stochastic Oscillator
- IDYA 1.84
- BCAT 81.58
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.
About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.